Roginolisib
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Roginolisib, covering 2026-01-16 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis [Phase 1]